Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fusion Genes and RNAs in Cancer Development. | Noncoding RNA | 2021 | 33557176 | PubTator, text mining | PubMed |
| Non-genetic heterogeneity, altered cell fate and differentiation therapy. | EMBO Mol Med | 2021 | 33555144 | PubTator, text mining | PubMed |
| TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients. | Cancers (Basel) | 2021 | 33546249 | PubTator, text mining | PubMed |
| Decoding the function of an oncogenic transcription factor: finding the first responders. | Mol Cell | 2021 | 33545056 | PubTator, text mining | PubMed |
| Menin is necessary for long term maintenance of meningioma-1 driven leukemia. | Leukemia | 2021 | 33542482 | PubTator, text mining | PubMed |
| Novel prognostic genes and subclasses of acute myeloid leukemia revealed by survival analysis of gene expression data. | BMC Med Genomics | 2021 | 33536020 | PubTator, text mining | PubMed |
| Patients with rare endocrine conditions have corresponding views on unmet needs in clinical research. | Endocrine | 2021 | 33534110 | PubTator, text mining | PubMed |
| MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3'UTR. | Exp Hematol Oncol | 2021 | 33531067 | PubTator, text mining | PubMed |
| CPMS-improving patient care in Europe via virtual case discussions. | Endocrine | 2021 | 33528763 | PubTator, text mining | PubMed |
| Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia. | Elife | 2021 | 33527899 | PubTator, text mining | PubMed |
| Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1. | Exp Hematol | 2021 | 33524443 | PubTator, text mining | PubMed |
| Studying Neutrophil Function in vitro: Cell Models and Environmental Factors. | J Inflamm Res | 2021 | 33505167 | PubTator, text mining | PubMed |
| The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study. | Clinics (Sao Paulo) | 2021 | 33503190 | PubTator, text mining | PubMed |
| Cytotoxic effect of CLL‑1 CAR‑T cell immunotherapy with PD‑1 silencing on relapsed/refractory acute myeloid leukemia. | Mol Med Rep | 2021 | 33495835 | PubTator, text mining | PubMed |
| Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re-induction chemotherapy. | Cancer Med | 2021 | 33491298 | PubTator, text mining | PubMed |
| The Importance of Targeted Next-Generation Sequencing Usage in Cytogenetically Normal Myeloid Malignancies. | Mediterr J Hematol Infect Dis | 2021 | 33489052 | PubTator, text mining | PubMed |
| Vitamin D improves pulmonary function in a rat model for congenital diaphragmatic hernia. | Arch Biochem Biophys | 2021 | 33484710 | PubTator, text mining | PubMed |
| RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia. | Nat Commun | 2021 | 33483506 | PubTator, text mining | PubMed |
| Prognostic Impacts of D816V KIT Mutation and Peri-Transplant RUNX1-RUNX1T1 MRD Monitoring on Acute Myeloid Leukemia with RUNX1-RUNX1T1. | Cancers (Basel) | 2021 | 33477584 | PubTator, text mining | PubMed |
| Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center. | Ann Hematol | 2021 | 33474629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=66